Understanding the differences in clinical outcomes and cost-effectiveness between available surgical options is critical for managing intertrochanteric femur fractures. The debate continues over the optimal fixation system, with many clinicians weighing the benefits of the Proximal Femoral Nail Antirotation (PFNA) against the Proximal Femoral Nail with Talon Locking System (PFN-TLS). With an aging population increasingly susceptible to such injuries, providing data-driven insights into surgical methodologies is vital for improving patient care and resource allocation.
Methods and Patient Analysis
The research conducted a retrospective cohort study, tracking 118 patients aged between 65 and 90 years, who received either PFNA or PFN-TLS treatment for intertrochanteric femur fractures. Over a minimum follow-up period of 24 months, several parameters were assessed, including surgical duration, functional outcomes, and economic viability. Notably, preoperative functional evaluations were not undertaken; thus, this analysis emphasizes postoperative data at the 24-month checkpoint.
Comparative Findings
The analysis showed notable differences between the two groups concerning surgical efficiency and patient outcomes. Patients treated with PFN-TLS experienced shorter surgeries, smaller incisions, and reduced exposure to fluoroscopy compared to the PFNA group. Furthermore, at 24 months, the PFN-TLS group displayed superior Harris Hip Scores, indicative of better functional recovery. Although the Visual Analog Scale and SF-36 scores did not differ significantly, the trends favored PFN-TLS.
– PFN-TLS reduced surgery duration and incision size compared to PFNA.
– Higher Harris Hip Scores were observed in PFN-TLS recipients.
– Revision rates leaned towards PFN-TLS, albeit non-significantly.
– PFN-TLS achieved marginally higher QALY gains at reduced costs.
Both fixation systems offered effective treatment for intertrochanteric femur fractures, but the PFN-TLS demonstrated clinical and cost advantages, leading to superior functional outcomes and economic efficiency. These findings recommend PFN-TLS as a preferable option for similar cases based on current evidence. However, the retrospective nature of the study implies that forthcoming research, ideally in the form of prospective randomized trials, remains essential to ascertain the broader applicability of these findings. Such studies would aid in refining implant selection and optimizing surgical practices further. As the healthcare landscape evolves, aligning surgical interventions with robust clinical evidence will ensure enhanced patient outcomes and cost efficiency in orthopedic practice.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
